|
Milestone Pharmaceuticals Inc. (Mist) Valation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Milestone Pharmaceuticals Inc. (MIST) Bundle
Améliorez vos choix d'investissement avec la calculatrice DCF Milestone Pharmaceuticals Inc. (MURS)! Explorez les données financières réelles pour un jalon, ajustez les projections et les dépenses de croissance et visualisez instantanément comment ces changements affectent la valeur intrinsèque de la brume.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 15.0 | 5.0 | 1.0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -66.67 | -80 | -100 | -61.67 | -61.67 | -61.67 | -61.67 | -61.67 |
| EBITDA | -50.7 | -43.0 | -58.4 | -56.8 | -42.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -286.53 | -1167.28 | -5684.5 | 100 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .4 | .4 | .5 | .1 | -3.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 2.41 | 9.6 | 9.2 | 100 | 44.24 | 44.24 | 44.24 | 44.24 | 44.24 |
| EBIT | -51.1 | -43.3 | -58.8 | -56.9 | -38.2 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -288.95 | -1176.88 | -5693.7 | 100 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 142.3 | 114.1 | 64.6 | 66.0 | 69.7 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .9 | .5 | 1.2 | 3.9 | 2.4 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 3.22 | 24.26 | 385.1 | 100 | 65.5 | 65.5 | 65.5 | 65.5 | 65.5 |
| Inventories | -.7 | -.4 | -.3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | -2.37 | -6.62 | 0 | 100 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 |
| Accounts Payable | 4.6 | 4.4 | 2.3 | 4.0 | 1.9 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 29.23 | 45.26 | 398.1 | 100 | 74.9 | 74.9 | 74.9 | 74.9 | 74.9 |
| Capital Expenditure | .0 | .0 | -.3 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 0 | -5.44 | -11.2 | 100 | -3.33 | -3.33 | -3.33 | -3.33 | -3.33 |
| Tax Rate, % | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 | 0.61994 |
| EBITAT | -51.1 | -43.1 | -57.6 | -56.9 | -38.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -46.3 | -42.9 | -60.2 | -58.2 | -42.5 | .5 | .0 | .0 | .0 | .0 |
| WACC, % | 6.85 | 6.85 | 6.82 | 6.85 | 6.84 | 6.84 | 6.84 | 6.84 | 6.84 | 6.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | 29 | |||||||||
| Equity Value | -29 | |||||||||
| Diluted Shares Outstanding, MM | 62 | |||||||||
| Equity Value Per Share | -0.47 |
What You Will Get
- Comprehensive Milestone Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Milestone Pharmaceuticals Inc. (MIST).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to suit your analysis.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Milestone Pharmaceuticals Inc.'s (MIST) fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to Milestone Pharmaceuticals Inc. (MIST).
- Time-Saving and Accurate: Eliminate the need to build models from scratch while ensuring precision and flexibility.
Key Features
- Comprehensive Financial Data: Gain access to precise historical data and future forecasts for Milestone Pharmaceuticals Inc. (MIST).
- Adjustable Forecast Parameters: Modify highlighted fields such as discount rates, growth projections, and profit margins.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Visualize your valuation outcomes with clear charts and concise summaries.
- Suitable for All Levels: Designed for investors, CFOs, and consultants with a straightforward and intuitive layout.
How It Works
- Step 1: Download the Excel file for Milestone Pharmaceuticals Inc. (MIST).
- Step 2: Review the pre-filled financial data and forecasts specific to Milestone Pharmaceuticals.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator?
- User-Friendly Interface: Tailored for both newcomers and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Feedback: Observe immediate changes to Milestone Pharmaceuticals Inc.'s (MIST) valuation as you modify inputs.
- Preloaded Data: Comes with Milestone Pharmaceuticals Inc.'s (MIST) actual financial metrics for swift evaluations.
- Relied Upon by Experts: Utilized by investors and analysts for making well-informed investment choices.
Who Should Use Milestone Pharmaceuticals Inc. (MIST)?
- Investors: Gain insights into the pharmaceutical market with comprehensive data and analysis tools.
- Healthcare Analysts: Streamline your research with ready-to-use financial models tailored for biotech companies.
- Consultants: Easily modify presentations and reports to showcase Milestone Pharmaceuticals Inc. (MIST) to clients.
- Pharmaceutical Enthusiasts: Enhance your knowledge of drug development and market strategies through detailed case studies.
- Educators and Students: Utilize it as a valuable resource for coursework in pharmaceutical finance and management.
What the Milestone Pharmaceuticals Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Milestone Pharmaceuticals Inc. (MIST).
- Real-World Data: Milestone Pharmaceuticals’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company’s performance.
- Key Ratios: Built-in analysis focusing on profitability, efficiency, and leverage specific to Milestone Pharmaceuticals.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.